In re DES Cases
United States District Court for the Eastern District of New York
789 F. Supp. 552 (1992)
- Written by Catherine Cotovsky, JD
Facts
Angela Silveri and others (plaintiffs) brought suit against Boehringer Ingelheim Pharmaceuticals, Inc., Boyle & Co., and several additional companies (manufacturers) (defendants) for injuries they suffered due to in utero exposure to diethylstilbestrol (DES), a synthetic estrogen that was widely manufactured and distributed throughout the United States in the 1950s and 1960s. Approximately half of the plaintiffs were residents of New York when suit was filed, and their mothers were presumed to be residents of New York when they ingested the DES that harmed the plaintiffs. The manufacturers were companies or successors of companies that operated plants that manufactured DES throughout the country, largely outside of New York. Some of the manufacturers were incorporated outside of New York and claimed to have never obtained licenses to do business in New York.
Rule of Law
Issue
Holding and Reasoning (Weinstein, J.)
What to do next…
Here's why 832,000 law students have relied on our case briefs:
- Written by law professors and practitioners, not other law students. 46,500 briefs, keyed to 994 casebooks. Top-notch customer support.
- The right amount of information, includes the facts, issues, rule of law, holding and reasoning, and any concurrences and dissents.
- Access in your classes, works on your mobile and tablet. Massive library of related video lessons and high quality multiple-choice questions.
- Easy to use, uniform format for every case brief. Written in plain English, not in legalese. Our briefs summarize and simplify; they don’t just repeat the court’s language.
